ACE2 News and Research

RSS
Anti-RBD antibodies shown to neutralize active SARS-CoV-2

Anti-RBD antibodies shown to neutralize active SARS-CoV-2

COVID-19 produces lung inflammation in non-human primate experiments

COVID-19 produces lung inflammation in non-human primate experiments

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

New study shows possible alternative pathway of SARS-CoV-2 infection in overactive bladder

New study shows possible alternative pathway of SARS-CoV-2 infection in overactive bladder

Indirect viral infection of the kidneys by SARS-CoV-2-induced inflammatory reaction

Indirect viral infection of the kidneys by SARS-CoV-2-induced inflammatory reaction

Census of viral spike protein antigens could benefit development of SARS-CoV-2 therapeutics

Census of viral spike protein antigens could benefit development of SARS-CoV-2 therapeutics

Synthetic monoclonal antibodies effectively neutralize SARS-CoV-2 in laboratory conditions

Synthetic monoclonal antibodies effectively neutralize SARS-CoV-2 in laboratory conditions

SARS-CoV-2 infection causes specific kidney proximal tubular injury

SARS-CoV-2 infection causes specific kidney proximal tubular injury

The receptor binding domain of the SARS-CoV-2

The receptor binding domain of the SARS-CoV-2

Inhibition of coronavirus spike protein binding to ACE2

Inhibition of coronavirus spike protein binding to ACE2

SARS-CoV-2 invasion of central nervous system through olfactory tract

SARS-CoV-2 invasion of central nervous system through olfactory tract

New strategy may facilitate development of multi-epitope peptide vaccine against SARS-CoV-2

New strategy may facilitate development of multi-epitope peptide vaccine against SARS-CoV-2

Designing a prototype spike protein vaccine for SARS-CoV-2

Designing a prototype spike protein vaccine for SARS-CoV-2

SARS-CoV-2 gene deletions may cause milder infections and increase human-to-human transmission

SARS-CoV-2 gene deletions may cause milder infections and increase human-to-human transmission

Alpaca-derived antiviral agent neutralizes SARS-CoV-2

Alpaca-derived antiviral agent neutralizes SARS-CoV-2

Potential new immunotherapy for critical COVID-19

Potential new immunotherapy for critical COVID-19

COVID-19 can increase stroke risk in young healthy people

COVID-19 can increase stroke risk in young healthy people

Blood group type may affect susceptibility to COVID-19 respiratory failure

Blood group type may affect susceptibility to COVID-19 respiratory failure

Scientists map how SARS-CoV-2 infects the airways

Scientists map how SARS-CoV-2 infects the airways

Does smoking increase COVID-19 risk?

Does smoking increase COVID-19 risk?